MAP Pharmaceuticals Presents Analyses Showing LEVADEX Effective when Administered at Various Times in Migraine Cycle and in Patients with Concomitant Asthma

Wednesday, June 23, 2010 General News
Email Print This Page Comment bookmark
Font : A-A+

-- FREEDOM-301 Analyses to be Presented at the AHS Annual Meeting --

CONTACTS:

Lisa Borland

MAP Pharmaceuticals, Inc.

(650) 386-3122

[email protected]

Nicole Foderaro

WCG

(415) 946-1058

[email protected]



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store